Class IOngoingD-0332-2026
Drug recall · February 11, 2026
Rheumacare capsules recall
Why: CGMP Deviations: product found to contain lead.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India UPC 8 904218 700313
- Lots / codes
Lot: CAM040, Exp. 06/30/2029 Lot: CAL079-N, Exp. 09/30/2028
- Quantity
- 4 bottles /30 capsules each
- Company
- Handelnine Global LLC, South Plainfield, NJ
- Distribution
- Product was distributed to one customer in NY.
- Initiated
- December 22, 2025 · Voluntary: Firm initiated
- Classified
- February 12, 2026
- Reported
- February 11, 2026
- How notified
- Press Release
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.